Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Casula

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Pharmacological Research|July 30, 2023
Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessmentFederica Galimberti, Manuela Casula, Elena Olmastroni
International Journal of Environmental Research and Public Health|February 11, 2023
Appropriateness of the Prescription and Use of Medicines: An Old Concept but More Relevant than EverManuela Casula, Ilaria Ardoino, Carlotta Franchi
Nutrients|March 12, 2022
Nutraceuticals for Dyslipidaemia and Glucometabolic Diseases: What the Guidelines Tell Us (and Do Not Tell, Yet)Manuela Casula, Alberico Luigi Catapano, Paolo Magni
Pharmacological Research|September 22, 2023
European guidelines for the treatment of dyslipidaemias: New concepts and future challengesAngela Pirillo, Manuela Casula, Alberico L Catapano
Patient Preference and Adherence|November 16, 2012
Adherence to lipid-lowering treatment: the patient perspectiveManuela Casula, Elena Tragni, Alberico Luigi Catapano
Clinical Pharmacology and Therapeutics|December 7, 2018
Lipid Lowering and Incidence of Cataract, a Role for FibratesManuela Casula, Angela Pirillo, Alberico L Catapano
Atherosclerosis. Supplements|February 16, 2021
Similarities and differences between European and American guidelines on the management of blood lipids to reduce cardiovascular riskLale Tokgözoğlu, Manuela Casula, Angela Pirillo, et al.
Atherosclerosis. Supplements|August 21, 2013
Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected]Manuela Casula, Davide Soranna, Alberico L Catapano, et al.
Atherosclerosis|October 2, 2018
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN studyManuela Casula, Elena Olmastroni, Angela Pirillo, et al.
Expert Opinion on Drug Discovery|February 7, 2018
Tools to investigate and avoid drug-hypersensitivity in drug developmentEmanuela Corsini, Manuela Casula, Elena Tragni, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Pharmacological Research|July 30, 2023
Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessmentFederica Galimberti, Manuela Casula, Elena Olmastroni
International Journal of Environmental Research and Public Health|February 11, 2023
Appropriateness of the Prescription and Use of Medicines: An Old Concept but More Relevant than EverManuela Casula, Ilaria Ardoino, Carlotta Franchi
Nutrients|March 12, 2022
Nutraceuticals for Dyslipidaemia and Glucometabolic Diseases: What the Guidelines Tell Us (and Do Not Tell, Yet)Manuela Casula, Alberico Luigi Catapano, Paolo Magni
Pharmacological Research|September 22, 2023
European guidelines for the treatment of dyslipidaemias: New concepts and future challengesAngela Pirillo, Manuela Casula, Alberico L Catapano
Patient Preference and Adherence|November 16, 2012
Adherence to lipid-lowering treatment: the patient perspectiveManuela Casula, Elena Tragni, Alberico Luigi Catapano
Clinical Pharmacology and Therapeutics|December 7, 2018
Lipid Lowering and Incidence of Cataract, a Role for FibratesManuela Casula, Angela Pirillo, Alberico L Catapano
Atherosclerosis. Supplements|February 16, 2021
Similarities and differences between European and American guidelines on the management of blood lipids to reduce cardiovascular riskLale Tokgözoğlu, Manuela Casula, Angela Pirillo, et al.
Atherosclerosis. Supplements|August 21, 2013
Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected]Manuela Casula, Davide Soranna, Alberico L Catapano, et al.
Atherosclerosis|October 2, 2018
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN studyManuela Casula, Elena Olmastroni, Angela Pirillo, et al.
Expert Opinion on Drug Discovery|February 7, 2018
Tools to investigate and avoid drug-hypersensitivity in drug developmentEmanuela Corsini, Manuela Casula, Elena Tragni, et al.
Pageof 11